Navigation Links
MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
Date:10/29/2010

amine (DHE), a drug used intravenously in clinical settings to effectively and safely treat migraines. Based on clinical results, the company believes that LEVADEX has the potential to provide both fast onset of action, sustained pain relief and other migraine symptom relief in an easy-to-use and non-invasive at-home therapy.

LEVADEX is designed to incorporate the multiple beneficial mechanisms of action that allow DHE to block initiation of migraine, limit pain, reduce inflammation and stop a migraine at any point in the migraine cycle. Based on research to date, including the efficacy portion of the FREEDOM-301 trial, the company believes the unique pharmacokinetic profile of LEVADEX has the potential to effectively treat migraines, while minimizing the side effects commonly seen with DHE and other currently available medicines.

About Migraine Common symptoms of migraine include recurrent headaches, nausea, vomiting, photophobia (sensitivity to light) and phonophobia (sensitivity to sound). According to the National Headache Foundation, most migraines last between four and 24 hours, but some last as long as three days. On average, migraine sufferers experience 1.5 migraine attacks monthly, although 25 percent of them experience one or more attacks weekly, according to published studies. Migraine patients report that currently approved drugs do not fully meet their needs due to slow onset of action, short duration of effect, inconsistent response and unacceptable side effect profiles. The economic burden of migraine remains substantial despite existing treatments, with the direct and indirect costs of migraine in the United States estimated at over $20 billion annually.

About MAP Pharmaceuticals MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The Company is developing LEVADEX inhaled therapy for the
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014  Today, Levi ... new extension to its PageCenterX ® content ... is designed to provide downtime reporting capabilities to ... LRS is releasing the product for general availability, ... EMR applications experience outages for a variety of ...
(Date:7/31/2014)... 2014 Orexigen® Therapeutics, Inc. (Nasdaq: ... quarter 2014, on Thursday, August 7, 2014 before markets ... webcast and conference call at 8:00 a.m. Eastern time ... host the call and webcast to discuss financial results ... accessed by calling (800) 708-4540 (domestic) or (847) 619-6397 ...
(Date:7/31/2014)... , July 31 2014  Northsight Capital, Inc. ... has been named Chairman and CEO of the company. ... management, legal matters, business development and investment banking. Mr. ... securities industry.  Before his career on Wall Street, Mr. ... of the U.S, Securities and Exchange Commission in ...
Breaking Medicine Technology:LRS Announces Downtime Reporting Solution for Healthcare 2Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Northsight Capital, Inc. Names Wall Street Veteran John Bluher, Former EVP And General Counsel Of Knight Trading Group, Chairman And CEO. 2
... PALO ALTO, Calif., May 3, 2011 Jazz Pharmaceuticals, Inc. (Nasdaq: ... first quarter of 2011. Total revenues for ... to $35.2 million for the first quarter of 2010.  Total ... GAAP net income for the first quarter of 2011 ...
... 3, 2011 Coast Dental Services, Inc., announced today ... the assets of Dental Technology, Inc. (DTI), doing business ... licensed  health care service plan. DTI and its subsidiaries ... Texas, employing 1,200 staff members, including 130 dentists.  The ...
Cached Medicine Technology:Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 2Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 3Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 4Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 5Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 6Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 7Coast Dental to Acquire the Assets of SmileCare 2
(Date:7/31/2014)... Reserve University medical and nursing school researchers hope ... patients who participate in clinical trials, a critical ... preventions. , For various reasonsincluding a lack of ... of cancer patients take part in trials of ... cancer patients who are eligible still don,t enroll, ...
(Date:7/31/2014)... Thousands of independent community pharmacists, ... have come together today to kick off ThoughtSpot ... , "ThoughtSpot 2014 is Good Neighbor Pharmacy’s annual ... to help their businesses thrive," stated AJ Caffentzis, ... long-standing commitment to independent community pharmacies, and at ...
(Date:7/31/2014)... India (PRWEB) July 31, 2014 Web ... an ISO 9001:2008 certified internet marketing firm, has recently ... order to make this service affordable for everyone, the ... of the service. , Web Programming Services has ... the world of brochure designing and likely expectations of ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Recently, Agebc.com, a ... dresses, has revealed its new selection of trendy mother ... them are offered at promotional prices now, up to 68% ... line by adding the new range of mother of the ... to the international clients. So far, our online shop has ...
(Date:7/31/2014)... Calif., July 31, 2014 -- A new study by ... that a peptide called caerulein can convert existing cells ... 1 diabetes-insulin-producing beta cells. The study, published online July ... a new approach to treating the estimated 3 million ... living with type 1 diabetes. , "We have found ...
Breaking Medicine News(10 mins):Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 2Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 3Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 2Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 3Health News:Web Programming Services Introduces Affordable Brochure Designing Service 2Health News:Mother of the Bride Dresses Now Available With Great Discounts at Agebc.com 2Health News:A new way to generate insulin-producing cells in Type 1 diabetes 2
... with four additional law suits, after the Liver Transplant Program ... ,Orange county Superior court has been a witness ... died just waiting for the transplants; the fourth, a patient ... program transparent to gross mismanagement has to also battle the ...
... are on tenterhooks, preventing the spread of the deadly virus H5N1, ... Eastern past of France. // The farm in Versailleux,on Thursday, that ... the lake where wild ducks were among the first to get ... ,This is perhaps the first time that a European Union farm ...
... prison in Guantanamo Bay to force feed the prisoners ... // through their noses has raised controversies among medical ... the fundamental principles of medical ethics. ,In ... targeted at extension of co-operation by the detainees. A ...
... mosquito-borne disease for which there is no known cure or ... of La Reunion Island // on Indian Ocean. As Nearly ... Xavier Bertrand, French Health Minister. ,More than 130, ... mortalities could be related directly or indirectly to the epidemic ...
... and unwholesomeness of visually appetizing foods, sugar coated cereals ... food strategies,// and yo-yo to consumer palettes, dictated by ... to keep heart disease and cancer at bay. ... a nutrition expert at the University of Maryland, ...
... offered insights into why Africans have an increased susceptibility ... compared to whites. // Worldwide, approximately more than ... 2 million people die due to the same every ... to official sources, the incidence of TB is eight ...
Cached Medicine News:Health News:Medical Ethics Violated By Prison Officials In Guantanamo Bay 2Health News:Wholly Ingrained: White or Brown? Food War Going Racist? Get to the Heart of the Matter 2Health News:Vitamin D May Help In Fight Against Tuberculosis 2
The first book to translate key medical data into clear guidelines capturing the highest treatment standards for heart disease....
... Reviews enable all those involved with healthcare ... the very latest evidence in their field ... harder each year as the volume of ... by delivering the best single source available ...
... topics included: Ergogenic aids, anabolic steroids, ... swimming, skiing, tennis, common sports problems, ... cardiology for athletes, exercise, exercise (treadmill) ... injuries, heat-related illness, acclimatization, neuropraxia, overtraining ...
Pocket Sports Medicine is the result of a collaboration between outstanding Editors and Contributors. The program covers the field so that both specialists and general orthopedists will find expert g...
Medicine Products: